Welcome to our dedicated page for AXCELIS TECHNOLOGIES SEC filings (Ticker: ACLS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on AXCELIS TECHNOLOGIES's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into AXCELIS TECHNOLOGIES's regulatory disclosures and financial reporting.
Axcelis Technologies President and CEO Russell Low reported a tax-related share disposition connected to the vesting of performance-based restricted stock units granted in May 2024. On the tax-withholding date, 5,227 shares of common stock were forfeited at $86.58 per share to cover tax obligations.
After this withholding, Low directly held 130,928 shares of Axcelis common stock, including 79,638 shares issuable upon vesting of restricted stock units that remain subject to forfeiture.
Axcelis Technologies reports 2025 revenue of $839.0 million, down from $1,017.9 million in 2024, as the cyclical semiconductor capital equipment market softened. Systems revenue fell to $571.0 million, while gross margin held essentially steady at 44.9% versus 44.7%.
Operating profit declined to $119.3 million and net income to $120.2 million, reflecting lower volumes despite stable profitability per dollar of sales. Aftermarket CS&I revenue grew to $268.0 million, or 31.9% of total revenue, highlighting a larger recurring service base. Systems backlog was $457.0 million at year-end, below $645.8 million in 2024.
The company remains focused on ion implantation, competing mainly with Applied Materials and several Asian rivals, and faces elevated U.S. export-control risk around Chinese customers. Axcelis also outlines risks and terms of its planned all‑stock merger with Veeco, including a fixed 0.3575 exchange ratio for Veeco shares and required regulatory approvals.
Axcelis Technologies director Jorge Titinger sold 1,000 shares of common stock in an open-market transaction at $80.00 per share on February 20, 2026. After this sale, he directly held 6,477 shares, including 3,586 shares issuable upon vesting of restricted stock units granted under the 2012 Equity Incentive Plan that remain subject to forfeiture.
Jorge Titinger reported a sale of 2,000 common shares. The sale is shown as executed on 12/17/2025 for $172,100. The filing also lists restricted stock vesting events of 115 shares on 08/15/2022 and 885 shares on 05/25/2025.
Axcelis Technologies reported lower results for the fourth quarter and full year 2025 while highlighting strong aftermarket performance and progress on its pending merger with Veeco. Full-year revenue was $839.0 million, down from $1,017.9 million in 2024, with GAAP diluted EPS falling from $6.15 to $3.80. Fourth-quarter revenue declined to $238.3 million from $252.4 million, and GAAP diluted EPS slipped to $1.10 from $1.54. Management emphasized record CS&I (aftermarket) revenue, expanded gross margins, and more than $100 million of free cash flow for 2025, alongside returning over $120 million to shareholders. For Q1 2026, the company guides to revenue of about $195 million, GAAP EPS of roughly $0.38, and non-GAAP EPS of about $0.71, reflecting ongoing transaction and integration costs related to the planned Veeco merger.
Reinhart Partners has disclosed a significant ownership stake in Axcelis Technologies Inc. common stock. The firm reports beneficial ownership of 1,589,898 shares, representing 5.18% of the outstanding common shares as of 12/31/2025.
Reinhart holds sole voting power over 1,457,777 shares and sole dispositive power over 1,589,898 shares, with no shared voting or dispositive authority. The firm certifies these securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Axcelis.
Axcelis Technologies reported that its stockholders overwhelmingly approved key proposals related to the company’s pending merger with Veeco Instruments. At a special meeting, 25,228,112 shares, or about 82.18% of eligible voting power, were represented, establishing a quorum.
Stockholders approved the share issuance needed to complete the merger, with 24,128,309 votes (95.84%) in favor and 1,048,205 (4.16%) against, and also approved a potential adjournment proposal, though it was not needed. The merger still requires remaining regulatory approvals, including from China’s State Administration for Market Regulation, and is expected to close in the second half of 2026.
Axcelis Technologies reported that its stockholders approved key proposals related to the company’s pending merger with Veeco Instruments at a special meeting on February 6, 2026. Shareholders backed the issuance of Axcelis common stock required under the merger agreement, with 24,128,309 votes, or 95.84% of votes cast, in favor and 1,048,205 against. A related proposal to adjourn the meeting if more votes were needed also passed, with 92.86% support, but was not required. The meeting had strong participation, with 25,228,112 shares present in person or by proxy out of 30,699,201 shares outstanding as of the record date. Completion of the merger remains subject to customary closing conditions, including final approval from China’s State Administration for Market Regulation, and Axcelis and Veeco continue to expect closing in the second half of 2026.
Axcelis Technologies filed an update on its planned merger with Veeco Instruments, outlining progress on regulatory clearances and closing conditions. The United Kingdom Investment Security Unit issued a no further action letter on January 22, 2026, removing one regulatory hurdle.
Axcelis and Veeco determined that filings under Sweden’s Investment Screening Law are not required and subsequently waived the related closing condition. They are still working toward final approval from China’s State Administration for Market Regulation. The merger also depends on customary conditions, including Axcelis and Veeco stockholder approvals at special meetings scheduled for February 6, 2026, and both ISS and Glass Lewis have recommended voting FOR. The companies continue to expect completion in the second half of 2026.
Axcelis Technologies, Inc. provides an update on regulatory and shareholder approval progress for its pending merger with Veeco Instruments Inc. Axcelis reports that the U.K. Investment Security Unit issued a “no further action” letter for the merger, removing one regulatory hurdle. The companies also determined that filings are not required under Sweden’s Investment Screening Law and subsequently waived the related closing condition.
The merger still depends on remaining conditions, including final regulatory approval from China’s State Administration for Market Regulation and stockholder approvals at both companies. Special meetings for Axcelis and Veeco stockholders are scheduled for February 6, 2026, and proxy advisory firms Institutional Shareholder Services and Glass Lewis have recommended that stockholders vote in favor of the deal. Axcelis and Veeco continue to state that they expect the merger to close in the second half of 2026.